Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study
- PMID: 36215712
- DOI: 10.7326/M22-1325
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study
Abstract
Background: Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was recommended by the U.S. Preventive Services Task Force (USPSTF) in 2013, making approximately 8 million Americans eligible for screening. The demographic characteristics and adherence of persons screened in the United States have not been reported at the population level.
Objective: To define sociodemographic characteristics and adherence among persons screened and entered into the American College of Radiology's Lung Cancer Screening Registry (LCSR).
Design: Cohort study.
Setting: United States, 2015 to 2019.
Participants: Persons receiving a baseline LDCT for LCS from 3625 facilities reporting to the LCSR.
Measurements: Age, sex, and smoking status distributions (percentages) were computed among persons who were screened and among respondents in the 2015 National Health Interview Survey (NHIS) who were eligible for screening. The prevalence between the LCSR and the NHIS was compared with prevalence ratios (PRs) and 95% CIs. Adherence to annual screening was defined as having a follow-up test within 11 to 15 months of an initial LDCT.
Results: Among 1 159 092 persons who were screened, 90.8% (n = 1 052 591) met the USPSTF eligibility criteria. Compared with adults from the NHIS who met the criteria (n = 1257), screening recipients in the LCSR were older (34.7% vs. 44.8% were aged 65 to 74 years; PR, 1.29 [95% CI, 1.20 to 1.39]), more likely to be female (41.8% vs. 48.1%; PR, 1.15 [CI, 1.08 to 1.23]), and more likely to currently smoke (52.3% vs. 61.4%; PR, 1.17 [CI, 1.11 to 1.23]). Only 22.3% had a repeated annual LDCT. If follow-up was extended to 24 months and more than 24 months, 34.3% and 40.3% were adherent, respectively.
Limitations: Underreporting of LCS and missing data may skew demographic characteristics of persons reported to be screened. Underreporting of adherence may result in underestimates of follow-up.
Conclusion: Approximately 91% of persons who had LCS met USPSTF eligibility criteria. In addition to continuing to target all eligible adults, men, those who formerly smoked, and younger eligible patients may be less likely to be screened. Adherence to annual follow-up screening was poor, potentially limiting screening effectiveness.
Primary funding source: None.
Comment in
-
Lessons From Implementation of the U.S. Preventive Services Task Force Recommendations for Lung Cancer Screening.Ann Intern Med. 2022 Nov;175(11):1608-1609. doi: 10.7326/M22-2886. Epub 2022 Oct 11. Ann Intern Med. 2022. PMID: 36215711 No abstract available.
Similar articles
-
Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.Chest. 2023 Jul;164(1):241-251. doi: 10.1016/j.chest.2023.02.003. Epub 2023 Feb 10. Chest. 2023. PMID: 36773935 Free PMC article.
-
Positive Screens Are More Likely in a National Lung Cancer Screening Registry Than the National Lung Screening Trial.J Am Coll Radiol. 2025 Jun;22(6):644-652. doi: 10.1016/j.jacr.2025.02.012. Epub 2025 Feb 27. J Am Coll Radiol. 2025. PMID: 40023436
-
Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.JAMA Netw Open. 2022 Nov 1;5(11):e2243163. doi: 10.1001/jamanetworkopen.2022.43163. JAMA Netw Open. 2022. PMID: 36409492 Free PMC article.
-
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: A Collaborative Modeling Study for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-2. PMID: 33750088 Free Books & Documents. Review.
-
Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2021 Mar 9;325(10):971-987. doi: 10.1001/jama.2021.0377. JAMA. 2021. PMID: 33687468
Cited by
-
What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening.Am J Respir Crit Care Med. 2024 Jan 15;209(2):197-205. doi: 10.1164/rccm.202301-0155OC. Am J Respir Crit Care Med. 2024. PMID: 37819144 Free PMC article.
-
Inconsistencies in predictive models based on exhaled volatile organic compounds for distinguishing between benign pulmonary nodules and lung cancer: a systematic review.BMC Pulm Med. 2024 Nov 2;24(1):551. doi: 10.1186/s12890-024-03374-2. BMC Pulm Med. 2024. PMID: 39488679 Free PMC article.
-
"We need to work towards it, whatever it takes."-participation factors in the acceptability and feasibility of lung cancer screening in Australia: the perspectives of key stakeholders.Transl Lung Cancer Res. 2024 Feb 29;13(2):240-255. doi: 10.21037/tlcr-23-623. Epub 2024 Feb 21. Transl Lung Cancer Res. 2024. PMID: 38496699 Free PMC article.
-
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum.Cancer Epidemiol Biomarkers Prev. 2024 Aug 1;33(8):984-988. doi: 10.1158/1055-9965.EPI-23-1491. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39012954 Free PMC article.
-
Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations.J Natl Compr Canc Netw. 2024 Mar 15;22(3):151-157. doi: 10.6004/jnccn.2023.7094. J Natl Compr Canc Netw. 2024. PMID: 38489927 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous